Evidence map›Paper›PMID 42807936›Full record

ReviewFrontiers in bioengineering and biotechnology2026

Early considerations for village-in-a-dish platform: a multidisciplinary perspective.

Talha Qureshi, Anna Bertocci, Ken Redekop, Pieter Vandekerckhove, Maarten IJzerman, Joyce van Meurs, Carin Uyl-de Groot, Roberto Narcisi

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Talha QureshiDelft Centre for Entrepreneurship, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
Anna BertocciDepartment Orthopaedics and Sports Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.
Ken RedekopDelft Centre for Entrepreneurship, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
Pieter VandekerckhoveDelft Centre for Entrepreneurship, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
Maarten IJzermanDelft Centre for Entrepreneurship, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
Joyce van MeursDepartment of Internal Medicine and Orthopaedics and Sports Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.
Carin Uyl-de GrootDelft Centre for Entrepreneurship, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands.
Roberto NarcisiDepartment Orthopaedics and Sports Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The conventional cell culture models are not suitable for large-scale studies of genetic variation in disease mechanisms and drug response due to technical variability, high cost, and labor associated with them. Multiplex cell culture approaches, such as Village-in-a-Dish (ViaD), can address these limitations by enabling simultaneous studies of cells from many individuals in a single experiment. However, the multiplex design of ViaD poses several issues that differ from those of conventional cell culture. In this review, we identify and expound on the issues with ViaD and categorized them as platform-related (inherent to the design) or application-related (dependent on specific context or use). By providing a structured overview of these issues, our findings can help researchers incorporate key technical considerations during study design and interpretation and determine the context in which the multiplex cell culture approaches might be unsuitable.

Indexed as

conventional cell culturegenetic variationHTA core modelinduced pluripotent stem cellspersonalized medicinesingle-cell RNA sequencingvillage-in-a-dish

Identifiers

PMID42807936
PMCPMC13618218

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.